Udompornpitak, K.; Bhunyakarnjanarat, T.; Saisorn, W.; Manipuntee, C.; Plengplang, K.; Sittichaitaweekul, S.; Jenphatanapong, P.; Udomkarnjananun, S.; Kaewduangduen, W.; Ariya-anandech, K.;
et al. Polymeric Particle BAM15 Targeting Macrophages Attenuates the Severity of LPS-Induced Sepsis: A Proof of Concept for Specific Immune Cell-Targeted Therapy. Pharmaceutics 2023, 15, 2695.
https://doi.org/10.3390/pharmaceutics15122695
AMA Style
Udompornpitak K, Bhunyakarnjanarat T, Saisorn W, Manipuntee C, Plengplang K, Sittichaitaweekul S, Jenphatanapong P, Udomkarnjananun S, Kaewduangduen W, Ariya-anandech K,
et al. Polymeric Particle BAM15 Targeting Macrophages Attenuates the Severity of LPS-Induced Sepsis: A Proof of Concept for Specific Immune Cell-Targeted Therapy. Pharmaceutics. 2023; 15(12):2695.
https://doi.org/10.3390/pharmaceutics15122695
Chicago/Turabian Style
Udompornpitak, Kanyarat, Thansita Bhunyakarnjanarat, Wilasinee Saisorn, Chonnavee Manipuntee, Kittawat Plengplang, Samarch Sittichaitaweekul, Panisa Jenphatanapong, Suwasin Udomkarnjananun, Warerat Kaewduangduen, Kasirapat Ariya-anandech,
and et al. 2023. "Polymeric Particle BAM15 Targeting Macrophages Attenuates the Severity of LPS-Induced Sepsis: A Proof of Concept for Specific Immune Cell-Targeted Therapy" Pharmaceutics 15, no. 12: 2695.
https://doi.org/10.3390/pharmaceutics15122695
APA Style
Udompornpitak, K., Bhunyakarnjanarat, T., Saisorn, W., Manipuntee, C., Plengplang, K., Sittichaitaweekul, S., Jenphatanapong, P., Udomkarnjananun, S., Kaewduangduen, W., Ariya-anandech, K., Samaeng, A., Insin, N., Ritprajak, P., & Leelahavanichkul, A.
(2023). Polymeric Particle BAM15 Targeting Macrophages Attenuates the Severity of LPS-Induced Sepsis: A Proof of Concept for Specific Immune Cell-Targeted Therapy. Pharmaceutics, 15(12), 2695.
https://doi.org/10.3390/pharmaceutics15122695
